BLFS Q4 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

-$3M-119.7% YoY

Gross Profit

$8M-241.6% margin

Operating Income

$1M-40.5% margin

Net Income

$12M-363.9% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

-111.2%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$583,000

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$399M

Total Liabilities

$51M

Stockholders' Equity

$349M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$3M	$17M	-119.7%
Gross Profit	$8M	$9M	-8.7%
Operating Income	$1M	-$7M	+118.6%
Net Income	$12M	-$13M	+193.1%

Revenue Segments

Product

$28M100%